Literature DB >> 27835040

Developing a new algorithm for first and second trimester preeclampsia screening in twin pregnancies.

Ron Maymon1,2, Alla Trahtenherts3, Ran Svirsky1,2, Yaakov Melcer1,2, Liora Madar-Shapiro3, Esther Klog1,2, Hamutal Meiri3, Howard Cuckle2.   

Abstract

OBJECTIVES: Construct a new preeclampsia predicting algorithm in twins.
METHODS: Twins sampled at 10-13 and 16-20 gestational weeks and their marker values were log transformed into multiples of the gestation-specific medians (MoMs) for singletons and entered into a new logistic regression model with/without prior risk factors.
RESULTS: The cohort included 9 PE (18 samples) and 96 unaffected cases (175 samples) twin pregnant women. The algorithm constructed of PlGF, PAPP-A, PP13, Doppler UTPI, and MAP with prior risk factors generated an area under the curve of 0.918, 75% detection rate for 10% false-positive rate.
CONCLUSIONS: The algorithm effectively forecasted twin risk to develop PE.

Entities:  

Keywords:  Doppler UTPI; MAP; PAPP-A; PP13; PlGF

Mesh:

Substances:

Year:  2016        PMID: 27835040     DOI: 10.1080/10641955.2016.1242605

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  3 in total

1.  A New Model for the Predicting the Risk of Preeclampsia in Twin Pregnancy.

Authors:  Qing Han; Shuisen Zheng; Rongxin Chen; Huale Zhang; Jianying Yan
Journal:  Front Physiol       Date:  2022-04-08       Impact factor: 4.755

2.  Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration.

Authors:  Tijana Drobnjak; Anna Margrét Jónsdóttir; Helga Helgadóttir; Margrét Soffía Runólfsdóttir; Hamutal Meiri; Marei Sammar; George Osol; Maurizio Mandalà; Berthold Huppertz; Sveinbjörn Gizurarson
Journal:  Int J Womens Health       Date:  2019-03-27

Review 3.  Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia-A Systematic Review.

Authors:  Katarzyna Kosinska-Kaczynska; Magdalena Zgliczynska; Szymon Kozlowski; Lukasz Wicherek
Journal:  J Clin Med       Date:  2020-01-09       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.